Index of artpub/2018/pmc_30318515/

Melisi, Davide
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
2018
https://ddd.uab.cat/record/228042
[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1=Melisi,_Davide2022-06-29 13:33 15  
[ ]2=Galunisertib_plus_gemcitabine_vs._gemcitabine...2022-06-29 13:33 119  
[ ]3=20182022-06-29 13:33 5  
[ ]4=2280422022-06-29 13:33 34  
[TXT]pmc_30318515.dirinfo2024-10-02 04:40 342  
[ ]pmc_30318515.du2024-10-02 04:40 35  
[TXT]pmc_30318515.dupdirs2024-10-02 04:40 0  
[TXT]pmc_30318515.dupfiles2024-10-02 04:40 0  
[TXT]pmc_30318515.errors2024-10-02 04:40 0  
[IMG]pmc_30318515.gif2024-10-02 04:40 40K 
[IMG]pmc_30318515.ico2024-10-02 04:40 12K 
[TXT]pmc_30318515.info2024-10-02 04:40 48K 
[TXT]pmc_30318515.md52024-10-02 04:40 51  
[ ]pmc_30318515.pdf2024-10-02 04:40 1.3M 
[TXT]pmc_30318515.sha12024-10-02 04:40 59  
[TXT]pmc_30318515.sha2562024-10-02 04:40 83  
[TXT]pmc_30318515.stats2024-10-02 04:40 250  
[TXT]pmc_30318515.txt2024-10-02 04:40 75K